Belpointe Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,340
| Closed | -$80.6K | – | 2398 |
|
|
2023
Q1 | $80.6K | Sell |
1,340
-218
| -14% | -$13.1K | ﹤0.01% | 1436 |
|
|
2022
Q4 | $114K | Sell |
1,558
-40
| -3% | -$2.93K | 0.01% | 1168 |
|
|
2022
Q3 | $121K | Sell |
1,598
-450
| -22% | -$34.1K | 0.01% | 1060 |
|
|
2022
Q2 | $142K | Buy |
2,048
+126
| +7% | +$8.74K | 0.01% | 962 |
|
|
2022
Q1 | $159K | Sell |
1,922
-49
| -2% | -$4.05K | 0.01% | 1008 |
|
|
2021
Q4 | $148K | Buy |
+1,971
| New | +$148K | 0.01% | 1021 |
|